Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles

Cell

Volumn 70, Issue 6, 1992, Pages 937-948

  Yin, Yuxin ^a   Tainsky, Michael A ^b   Bischoff, Farideh Z ^b   Strong, Louise C ^b   Wahl, Geoffrey M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DNA REPLICATION; DNA SYNTHESIS; FIBROBLAST; GENE AMPLIFICATION; GENE EXPRESSION; GENE INDUCTION; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ASPARTIC ACID; BASE SEQUENCE; CELL CYCLE; CHROMOSOME DELETION; FIBROBLASTS; G1 PHASE; GENE AMPLIFICATION; GENES, P53; HUMAN; LI-FRAUMENI SYNDROME; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHONOACETIC ACID; S PHASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SUPPRESSION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0026801977     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(92)90244-7     Document Type: Article

References (89)

1. The age distribution of cancer and a multi-stage theory of carcinogenesis
2. Accumulation of DNA strand breaks during thymineless death in thymidylate synthase-negative mutants of mouse FM3A cells
3. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
4. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
5. Karyotypic evolution in human malignant melanoma
6. An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine
7. Chromosomal organization of amplified genes in multidrug-resistant Chinese hamster cells
8. Spontaneous immortalization of normal fibroblasts from patients with Li-Fraumeni cancer syndrome
9. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2
10. Mouse p53 inhibits SV40 origin-dependent DNA replication
11. Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea
12. Mapping of the gene encoding the multifunctional protein carrying out the first three steps of pyrimidine biosynthesis to human chromosome 2
13. Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene
14. Electroporation for the efficient transfection of mammalian cells with DNA
15. DNA repair in man
16. Organization and nucleotide sequence of the 3′ end of the human CAD gene
17. Mathematical analysis of DNA distributions from flow microfluorometry
18. p53 functions as a cell cycle control protein in osteosarcomas
19. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
20. Characterization of chromosome aberrations induced by incubation at a restrictive temperature in the mouse temperature-sensitive mutant tsFT20 strain containing heat-labile DNA polymerase α
21. Definition of a consensus binding site for p53
22. A genetic model for colorectal tumorigenesis
23. Presence of a potent transcription activating sequence in the p53 protein
24. Moderate-level gene amplification in methotrexate-resistant Chinese hamster ovary cells is accompanied by chromosomal translocation at or near the site of the amplified DHFR gene
25. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression
26. A transcriptionally active DNA-binding site for human p53 protein complexes
27. p53 and DNA polymerase α compete for binding to SV40 T antigen
28. 1-Beta-d-arabinofur-anosylcytosine enhancement of resistance to several antineoplastic drugs in mammalian tissue culture cells
29. Chromosomal changes without DNA over-production in hydroxyurea-treated mammalian cells: implications for gene amplification
30. DNA sequence amplification in mammalian cells
31. Checkpoints: controls that ensure the order of cell cycle events
32. Excision of N-myc from chromosome 2 in human neuroblastoma cells containing amplified N-myc sequences
33. Clonal genomic alterations in glioma malignancy stages
34. Participation of p53 protein in the cellular response to DNA damage
35. Identification of p53 as a sequence-specific DNA-binding protein
36. Oncogenic forms of p53 inhibit p53-regulated gene expression
37. Thymineless death and mutation induction in cultured mouse FM3A cell mutants deficient in thymidylate synthase
38. A reversible arrest point in the late G1 phase of the mammalian cell cycle
39. p53: oncogene or anti-oncogene?
40. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus
41. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene
42. The p53 tumour suppressor gene
43. Rhabdomyosarcoma in children: epidemiology study and identification of a familial cancer syndrome
44. A cancer family syndrome in twenty-four kindreds
45. Normal cytoxic response of skin fibroblasts from patients with Li-Fraumeni cancer syndrome to DNA-damaging agents in vitro
46. Germ line p53 mutations in a familial syndrome of sarcomas, breast cancer and other neoplasms
47. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein
48. The p53 tumor suppressor protein is phosphorylated at serine 389 by casein kinase II
49. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53
50. p53 is associated with p34cdc2 in transformed cells
51. Tumor suppressor p53: analysis of wild-type and mutant p53 complexes
52. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
53. A cytogenetic investigation of DNA rereplication after hydroxyurea treatment: implications for gene amplification
54. Kinetics of N-(phosphonacetyl)-l-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells
55. Mechanisms of p53 loss in human sarcomas
56. Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30]
57. Mutations in the p53 gene occur in diverse human tumour types
58. Genetic instability in cancer cells: relationship to tumor cell heterogeneity
59. Increased incidence of CAD gene amplification in tumorigenic rat lines as an indicator of genomic instability of neoplastic cells
60. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization
61. Progression to cancer in Barrett's esophagus is associated with genomic instability
62. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene
63. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells
64. Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and dioxorubicin (adriamycin) resistance
65. Gene amplification in cultured cells
66. Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration
67. Germ-line transmission of a mutated p53 gene in a cancerprone family with Li-Fraumeni syndrome
68. DNA amplification in drug-resistant cells and in tumors
69. Gene amplification
70. Analysis of cancer incidence data on the basis of multistage and clonal growth models
71. Mouse p53 blocks SV40 DNA replication in vitro and downregulates T antigen DNA helicase activity
72. p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis
73. n-(phosphonacetyl)-l-aspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture
74. p53: a frequent target for genetic abnormalities in lung cancer
75. Normal diploid human and rodent cells lack a detectable frequency of gene amplification
76. Enhanced frequency of generation of methotrexate resistance and gene amplification in cultured mouse and hamster cell lines
77. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbruck fluctuation analysis
78. Genetic alterations during colorectal-tumor development
79. Gene amplification causes overproduction of the first three enzymes of UMP in n-(phosphonacetyl)-l-aspartate resistant hamster cells
80. The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen
81. Phosphorylation sites in the amino terminal region of mouse p53
82. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae
83. The MCK enhancer contains a p53 responsive element
84. Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events
85. A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration
86. DNA amplification is rare in normal human cells
87. Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia
88. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein